Compare Live Nation Entertainment, Inc. (LYV) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Live Nation Entertainment, Inc. vs Mesoblast Limited — how do they compare? Live Nation Entertainment, Inc. trades at $180.98 (market cap $42.09B), while Mesoblast Limited trades at $16.38 (market cap $2.17B). The key difference: Live Nation Entertainment, Inc. is far larger — about 19.4× Mesoblast Limited's market cap, and Live Nation Entertainment, Inc. is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| LYV | MESO | |
|---|---|---|
Market Cap | $42.09B | $2.17B |
Sector | Industrials | Technology |
52-Week High | $186.59 | $20.96 |
52-Week Low | $125.61 | $12.88 |
Enterprise Value | $43.59B | $2.17B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Live Nation (LYV) trades at $177.83, down 1.33% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported $25.20B revenue for 2025 with a slim 0.33% net margin, while recent earnings misses have pressured sentiment. Strong cash flow from operations of $1.40B supports ongoing investments in live events, with analyst consensus overwhelmingly bullish at 88.6% buy ratings.
Outlook remains positive due to resilient live event demand and projected 2026 revenue growth to $25.60B, though risks include high valuation multiples (P/E 117.5), recent earnings misses, and sensitivity to consumer discretionary spending. The consensus price target of $201.50 suggests 13% upside potential from current levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
